DEL 22379
CAS: 181223-80-3
Ref. 3D-GHA22380
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
DEL 22379
Description:
DEL 22379 is a small molecule that inhibits the activity of histone deacetylases (HDACs) by binding to the enzyme and inhibiting its ability to modulate chromatin structure. Cell culture experiments have shown that DEL 22379 induces differentiation of stem cell-like cells in colorectal adenocarcinoma, suggesting that this compound may be useful as a therapeutic agent for colon cancer. The potential of DEL 22379 as an anticancer drug has been assessed experimentally using kinetic data from cell culture experiments. The results show that DEL 22379 has anti-angiogenic properties and can inhibit tumor growth and metastasis.
The following table contains the five most common types of cancer treatments:
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
444.53 g/mol
Formula:
C26H28N4O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
